(Q46859144)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

meta-analysis

0 references

title

HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Alain Hovnanian

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Emmanuelle Génin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Shuen-Iu Hung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Peggy Sekula

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

D-P Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M Schumacher

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

P-Y Chang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

S-H Tsai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

T-L Wu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

T Bellón

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

R Tamouza

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

C Fortier

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

D Charron

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

P Wolkenstein

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

W-H Chung

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M Mockenhaupt

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

J-C Roujeau

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

10 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

281-288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/tpj.2013.40

2 March 2020

exact match

0 references

cites work

A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Anticonvulsant hypersensitivity syndrome: incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Severe adverse cutaneous reactions to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

The DRESS syndrome: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Drug hypersensitivity: pharmacogenetics and clinical syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Medical genetics: a marker for Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

HLA-B locus in Caucasian patients with carbamazepine hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Human leukocyte antigen-A, -B, and -DRB1 haplotypes of cord blood units in the Tzu Chi Taiwan Cord Blood Bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Human leukocyte antigens and drug hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.40

21 January 2018

Identifiers

DOI

10.1038/TPJ.2013.40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322785%20AND%20SRC:MED&resulttype=core&format=json

release_jycncrprefa6pc6lhukrviuzs4

2 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jycncrprefa6pc6lhukrviuzs4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference